Security key
85209E109
Spruce Biosciences, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (SPRB)
CUSIP: 85209E109
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share (the "Shares")
- Total 13F shares
- 18,240,239
- Total 13F value
- $19,982,773
- Share change
- -27,408
- SEC-reported price per share
- $1.10
- Number of holders
- 30
- Value change
- -$50,960
- Number of buys
- 8
- Number of sells
- 13
- Shares outstanding
- 1,373,824
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
30
Top holders
10
SPRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
SPRUCE BIOSCIENCES, INC. SEC filings
SPRUCE BIOSCIENCES, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 85209E109
Recent filing periods:
Ownership snapshot
Top reported holders of SPRB - Spruce Biosciences, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 329%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 329%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
329%
Omega Fund Management, LLC
157%
RiverVest Venture Management LLC
156%
Abingworth LLP
130%
CITADEL ADVISORS LLC
126%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
329%
|
$6,185,000
4,514,336 shares
|
— | 30 Sep 2022 |
| Omega Fund Management, LLC |
13F
Company
|
157%
|
$2,961,000
2,161,022 shares
|
— | 30 Sep 2022 |
| RiverVest Venture Management LLC |
13F
Company
|
156%
|
$2,943,000
2,148,281 shares
|
— | 30 Sep 2022 |
| Abingworth LLP |
13F
Company
|
130%
|
$2,474,000
1,792,518 shares
|
— | 30 Sep 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
126%
|
$2,369,000
1,729,543 shares
|
— | 30 Sep 2022 |
| Rock Springs Capital Management LP |
13F
Company
|
118%
|
$2,223,000
1,622,689 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
18,240,239
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
30
Q4 2022 holders
30
Holder diff
0
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend